Thus, the inhibited ERK-induced phosphorylation of S235 in drug 3g-treated MM cells is not because of a general inhibition of the ERK mitogen-activated protein kinase cascade but, more likely, occurs secondary to a structural alteration of DEPTOR after drug binding. Here, WNK2 is linked to Miyoshi myopathy.